Search fresh public links, source activity, and ready-to-use post angles for Hemophilia A.
Fresh curated links around hemophilia A are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Hemophilia A is a rare inherited bleeding disorder and the most common type of hemophilia, accounting for about 80% of cases. It is caused by mutations in the F8 gene that lead to...
Hemophilia A, the most common type of hemophilia, is a bleeding disorder that is inherited in an X-linked, recessive manner. This is because the F8 gene, which can cause hemophilia...
Hemophilia A, a genetic bleeding disorder, is often underdiagnosed in women because of the historical misconception that it affects only men due to its inheritance pattern. While w...
There is no cure for hemophilia A, but several treatments are available to help prevent and control bleeds, reduce the risk of complications, and improve quality of life. People wi...
Hemophilia A is a bleeding disorder caused by a deficiency in the blood-clotting factor VIII (FVIII) protein. Standard treatment usually relies on factor replacement therapy, which...
Factor VIII (FVIII) replacement therapy is a cornerstone of treatment for many people with hemophilia A, a rare bleeding disorder caused by deficient or dysfunctional FVIII, a prot...
Inside hemophilia genetics, such as F8 and F9 mutations, inheritance patterns, and de novo variants. Plus, evolving approaches to females with hemophilia. The post Hemophilia As an...
Hemophilia is a rare disorder in which the blood doesn’t clot properly, resulting in the disease’s hallmark symptoms of bleeds — excessive bleeding that extends over a prolonged pe...
A look at how FVIII/FIX deficiency contributes to variable disease severity and provides the biologic foundation for modern hemophilia therapies. The post Bleeding Response in Hemo...
If you have hemophilia A, you may wonder what it means if your condition is classified as mild, moderate, or severe. While all forms of hemophilia A affect blood clotting, the seve...
Recognizing acquired hemophilia A (AHA) early and ordering simple blood clotting tests in older patients with unexplained bruising or anemia — a low number of red blood cells — may...
Brothers Julian and Caeleb MacDonald share how growing up with severe hemophilia A shaped their experiences, family dynamics, and sibling relationship, while emphasizing that their...
Obizur (susoctocog alfa) is a recombinant porcine (pig-derived) factor VIII concentrate approved for the on-demand treatment of bleeds in adults with acquired hemophilia A. The pos...
In a small study, children with hemophilia A had distinct changes in certain immune cells and inflammatory signaling molecules compared with healthy children, and the type of preve...
Although it’s often mistakenly thought of as a male disease, hemophilia affects a substantial number of women and girls, manifesting with symptoms that can include heavy menstrual...
Once-weekly infusions of Altuvoct (efanesoctocog alfa) — a long-lasting hemophilia treatment marketed in the U.S. as Altuviiio — reduced bleeding in adults and children with hemoph...
From acute bleeds and inhibitor considerations to long-term approaches. The post Hemophilia Management: Emergency Stabilization and Long-Term Strategies appeared first on Hemophili...
Long-term treatment with Hemlibra (emicizumab) provided sustained protection against bleeding for up to five years in people with hemophilia A, with no new safety concerns identifi...
Factor deficiencies can disrupt clot formation, causing bleeding complications, arthropathy, the development of inhibitors, and long-term disease burden. The post Management Challe...
Denecimig (Mim8), an investigational antibody therapy being developed by Novo Nordisk, continued to maintain low bleeding rates in children, adolescents, and adults with hemophilia...
Inside the evolving hemophilia treatment landscape, including AAV-based gene therapies, non-factor prophylaxis, and approaches that aim to reduce treatment burden. The post Gene an...
Shannon Walker, MD, discusses the importance of promptly treating acute hemophilia bleeds, sometimes before imaging is completed. The post Common mistakes in treating hemophilia bl...
Rebinyn (nonacog beta pegol) is a recombinant factor IX concentrate used to prevent and treat bleeds, including those occurring during surgery, in children and adults with hemophil...
Women and girls with hemophilia continue to face delayed diagnoses, unequal access to treatment, and underrepresentation in clinical trials, even though many experience significant...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.